Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Juno PC Holdings Pty Limited

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (11)
Cancellation by sponsor (3)
Prescription medicine registration (1)

Date

2026 (2)
2025 (3)
2021 (6)
2020 (3)
2019 (1)

Search

Sponsor content

15 result(s) found, displaying 11 to 15

JUNOPHEN ER phentermine (as hydrochloride) 15 mg extended release tablet blister pack (344059)

20 October 2021

ARTG

Australian Register of Therapeutic Goods (ARTG) information for JUNOPHEN ER phentermine (as hydrochloride) 15 mg extended release tablet blister pack.
JUNOMINE ER phentermine (as hydrochloride) 15 mg extended-release tablet blister pack (309915)

9 January 2020

ARTG

Australian Register of Therapeutic Goods (ARTG) information for JUNOMINE ER phentermine (as hydrochloride) 15 mg extended-release tablet blister pack.
JUNOMINE ER phentermine (as hydrochloride) 30 mg extended release tablet blister pack (309916)

9 January 2020

ARTG

Australian Register of Therapeutic Goods (ARTG) information for JUNOMINE ER phentermine (as hydrochloride) 30 mg extended release tablet blister pack.
JUNOMINE ER phentermine (as hydrochloride) 40 mg extended release tablet blister pack (309917)

9 January 2020

ARTG

Australian Register of Therapeutic Goods (ARTG) information for JUNOMINE ER phentermine (as hydrochloride) 40 mg extended release tablet blister pack.
JUNOMINE ER, PHENTERMINE JUNO ER (Juno PC Holdings Pty Limited)

2 October 2019

Prescription medicine registration

Active ingredients: phentermine hydrochloride.

Pages

First page
Previous page
Page 1
Current page 2

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.